Link Cell Therapies
$60.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Link Cell Therapies is currently valued at $110.5M as of December 15, 2025. The company has raised a total of $72.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.53x, Link Cell Therapies has achieved a valuation that is 1.53 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Link Cell Therapies's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Link Cell Therapies Worth in 2025?
As of 2025, Link Cell Therapies is valued at $110.5M, based on the company's Early Stage VC funding round in December 15, 2025. This valuation positions Link Cell Therapies as one of the leading private companies in the sector.
Link Cell Therapies Valuation History
Link Cell Therapies's funding history demonstrates steady growth and investor confidence.
How Link Cell Therapies Valuation is Determined
Private company valuations like Link Cell Therapies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Link Cell Therapies Valuation FAQs
Is Link Cell Therapies profitable?
Link Cell Therapies has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Link Cell Therapies's valuation compare to competitors?
Link Cell Therapies is valued at $110.5M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Link Cell Therapies IPO?
Link Cell Therapies has not announced plans for an initial public offering. Until an IPO, investors can access Link Cell Therapies shares through secondary market platforms.